2021 NIH Director's New Innovator Award (DP2 - Clinical Trial Optional): RFA-RM-20-012
2021 NIH Director's New Innovator Award (DP2 - Clinical Trial Optional): RFA-RM-20-012. Supports exceptionally creative early career scientists proposing unusually innovative and high-impact projects. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research.
- Early Stage Investigator only
- Single-PI applications only
- No preliminary data required
- $1.5 million in direct costs disbursed in first year of 5-year project period
- Application deadline: August 21, 2020